Lyell Wealth Management LP Has $2.86 Million Holdings in The Cigna Group (NYSE:CI)

Lyell Wealth Management LP trimmed its position in shares of The Cigna Group (NYSE:CI) by 1.6% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 9,553 shares of the health services provider’s stock after selling 156 shares during the period. Lyell Wealth Management LP’s holdings in The Cigna Group were worth $2,861,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the company. Tokio Marine Asset Management Co. Ltd. grew its stake in The Cigna Group by 8.6% during the fourth quarter. Tokio Marine Asset Management Co. Ltd. now owns 6,726 shares of the health services provider’s stock worth $2,014,000 after buying an additional 534 shares in the last quarter. Wynn Capital LLC acquired a new stake in The Cigna Group during the fourth quarter worth about $994,000. Watershed Asset Management L.L.C. grew its stake in The Cigna Group by 8.9% during the fourth quarter. Watershed Asset Management L.L.C. now owns 967 shares of the health services provider’s stock worth $290,000 after buying an additional 79 shares in the last quarter. Harvest Fund Management Co. Ltd grew its stake in The Cigna Group by 36.7% during the fourth quarter. Harvest Fund Management Co. Ltd now owns 391 shares of the health services provider’s stock worth $117,000 after buying an additional 105 shares in the last quarter. Finally, Cumberland Partners Ltd grew its stake in The Cigna Group by 23.1% during the fourth quarter. Cumberland Partners Ltd now owns 2,660 shares of the health services provider’s stock worth $794,000 after buying an additional 500 shares in the last quarter. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on CI shares. Deutsche Bank Aktiengesellschaft raised shares of The Cigna Group from a “hold” rating to a “buy” rating and increased their target price for the stock from $355.00 to $370.00 in a report on Thursday, February 1st. Mizuho increased their target price on shares of The Cigna Group from $360.00 to $370.00 and gave the stock a “buy” rating in a report on Monday, February 5th. Sanford C. Bernstein raised shares of The Cigna Group from a “market perform” rating to an “outperform” rating and increased their target price for the stock from $330.00 to $372.00 in a report on Thursday, January 4th. Wells Fargo & Company increased their target price on shares of The Cigna Group from $334.00 to $348.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 6th. Finally, Morgan Stanley reissued an “overweight” rating and issued a $392.00 target price (up previously from $382.00) on shares of The Cigna Group in a report on Monday, March 4th. Two investment analysts have rated the stock with a hold rating, ten have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and an average target price of $362.14.

The Cigna Group Trading Down 0.1 %

NYSE CI traded down $0.38 during trading hours on Wednesday, reaching $352.27. The company’s stock had a trading volume of 1,120,784 shares, compared to its average volume of 1,588,393. The firm has a fifty day simple moving average of $349.31 and a 200-day simple moving average of $317.09. The stock has a market cap of $102.99 billion, a P/E ratio of 20.26, a P/E/G ratio of 1.08 and a beta of 0.56. The Cigna Group has a 52 week low of $240.50 and a 52 week high of $365.71. The company has a debt-to-equity ratio of 0.61, a current ratio of 0.67 and a quick ratio of 0.67.

The Cigna Group (NYSE:CI) last released its earnings results on Friday, February 2nd. The health services provider reported $6.79 earnings per share for the quarter, beating analysts’ consensus estimates of $6.54 by $0.25. The business had revenue of $51.15 billion during the quarter, compared to the consensus estimate of $48.91 billion. The Cigna Group had a net margin of 2.64% and a return on equity of 13.59%. The company’s revenue for the quarter was up 11.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $4.96 EPS. Equities analysts forecast that The Cigna Group will post 28.36 earnings per share for the current fiscal year.

The Cigna Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, June 20th. Shareholders of record on Tuesday, June 4th will be given a dividend of $1.40 per share. This represents a $5.60 dividend on an annualized basis and a yield of 1.59%. The Cigna Group’s dividend payout ratio is presently 32.20%.

Insider Buying and Selling at The Cigna Group

In other news, CEO David Cordani sold 31,209 shares of The Cigna Group stock in a transaction on Monday, March 25th. The shares were sold at an average price of $355.17, for a total value of $11,084,500.53. Following the completion of the sale, the chief executive officer now owns 348,054 shares in the company, valued at approximately $123,618,339.18. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, CEO David Cordani sold 31,209 shares of The Cigna Group stock in a transaction on Monday, March 25th. The shares were sold at an average price of $355.17, for a total value of $11,084,500.53. Following the completion of the sale, the chief executive officer now owns 348,054 shares in the company, valued at approximately $123,618,339.18. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of The Cigna Group stock in a transaction on Wednesday, February 7th. The shares were sold at an average price of $330.48, for a total transaction of $1,608,446.16. Following the completion of the sale, the senior vice president now owns 2,102 shares of the company’s stock, valued at approximately $694,668.96. The disclosure for this sale can be found here. In the last 90 days, insiders sold 114,144 shares of company stock valued at $39,296,330. 0.70% of the stock is currently owned by company insiders.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.